Financial Fitness Check: Examining Neogenomics Inc. (NEO)’s Key Ratios

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Neogenomics Inc. (NASDAQ: NEO) closed at $14.50 down -0.96% from its previous closing price of $14.64. In other words, the price has decreased by -$0.96 from its previous closing price. On the day, 0.82 million shares were traded. NEO stock price reached its highest trading level at $15.07 during the session, while it also had its lowest trading level at $14.445.

Ratios:

For a deeper understanding of Neogenomics Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.93 and its Current Ratio is at 2.01. In the meantime, Its Debt-to-Equity ratio is 0.66 whereas as Long-Term Debt/Eq ratio is at 0.44.

On December 29, 2023, BTIG Research reiterated its Buy rating and also upped its target price recommendation from $25 to $21.

Stephens Upgraded its Equal-Weight to Overweight on August 21, 2023, while the target price for the stock was maintained at $18.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 15 ’24 when Olivo Alicia C sold 1,040 shares for $16.05 per share. The transaction valued at 16,695 led to the insider holds 43,813 shares of the business.

ALICIA OLIVO bought 1,040 shares of NEO for $16,453 on Aug 15 ’24. On Aug 15 ’24, another insider, BRUCE K CROWTHER, who serves as the Officer of the company, bought 8,353 shares for $15.95 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NEO now has a Market Capitalization of 1858290944 and an Enterprise Value of 2076956160. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.96 while its Price-to-Book (P/B) ratio in mrq is 2.02. Its current Enterprise Value per Revenue stands at 3.306 whereas that against EBITDA is -145.884.

Stock Price History:

Over the past 52 weeks, NEO has reached a high of $21.22, while it has fallen to a 52-week low of $11.03. The 50-Day Moving Average of the stock is -9.52%, while the 200-Day Moving Average is calculated to be -5.73%.

Shares Statistics:

For the past three months, NEO has traded an average of 747.24K shares per day and 770470 over the past ten days. A total of 127.37M shares are outstanding, with a floating share count of 126.47M. Insiders hold about 1.31% of the company’s shares, while institutions hold 98.90% stake in the company. Shares short for NEO as of 1726185600 were 5178528 with a Short Ratio of 6.93, compared to 1723680000 on 5015743. Therefore, it implies a Short% of Shares Outstanding of 5178528 and a Short% of Float of 5.609999999999999.

Most Popular